Teladoc Health Q1 2026 Earnings EPS Misses Expectations as Cost Pressures Persist COYA Q1 2026 Earnings NarrowerthanExpected Loss as Biotech Advances Pipeline Essex Property Trust ESS Q1 2026 Earnings EPS Surges Past Estimates on Strong Operating Performance CLRB Q1 2026 Earnings EPS Beat Signals Improved Cost Discipline IO Biotech Q3 2025 Earnings EPS Beat of 6067 Surprise but No Revenue from PreCommercial Pipeline ONON Q1 2026 Earnings Stellar EPS Beat Drives Positive Market Sentiment